Anni Saunajoki

Mrs. Anni Saunajoki


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Annals of Medicine
Verified
Journal Article
Open access
ASAnni Saunajoki
Anni Saunajoki
JAJuha Auvinen
Juha Auvinen
ABAini Bloigu
Aini Bloigu
OUOlavi Ukkola
Olavi Ukkola
SKSirkka Keinänen-Kiukaanniemi
Sirkka Keinänen-Kiukaanniemi
MTMarkku Timonen
Markku Timonen
To estimate the ability of fasting, 1-h, and 2-h post-load glucose to predict cardiovascular outcomes.We examined a population-based study consisting of 977 middle-aged subjects who underwent an or...

Verified
Journal Article
Open access
PDF file
ASAnni Saunajoki
Anni Saunajoki
JAJuha Auvinen
Juha Auvinen
ABAini Bloigu
Aini Bloigu
JSJouko Lauri Saramies
Jouko Lauri Saramies
JAAKKO TUOMILEHTOJAAKKO TUOMILEHTO
JAAKKO TUOMILEHTO
MTMarkku Timonen
Markku Timonen
The purpose of this study was to examine and compare the associations between albuminuria and fasting (FPG), 1 h post-load (1 h PG) and 2 h post-load plasma glucose (2 h PG) in an oral glucose tolerance test (OGTT). A total of 496 people free of known diabetes (mean age 72 years) participated in the examinations including the OGTT with plasma glucose measurements at 0, 1, and 2 h and levels of HbA1c. Albuminuria was determined by the urinary albumin-to-creatinine ratio and was defined as ≥3.0 mg/mmol. Compared with those without albuminuria, participants with albuminuria had significantly higher 1 h PG and 2 h PG levels, but not FPG or HbA1c levels. An elevated 1 h PG increased the estimated odds ratio of albuminuria more than three times in people with prediabetic 1 h PG (8.6–11.5 mmol/L: OR 3.60; 95% CI 1.70–7.64) and diabetic 1 h PG (≥11.6 mmol/L: OR 3.05; 95% CI 1.29–7.23). After adjusting for blood pressure and age, the association of elevated 1 h PG with albuminuria remained significant. Prediabetic or diabetic FPG, 2 h PG, or HbA1c did not have a statistically significant association with albuminuria. These findings suggest that 1 h PG seems to be the best glycemic parameter and is useful in recognizing persons with an elevated risk of early kidney disease due to hyperglycemia.

1 February 2020 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
ASAnni Saunajoki
Anni Saunajoki
JAJuha P. Auvinen
Juha P. Auvinen
ABAini H. Bloigu
Aini H. Bloigu
MTMarkku J. Timonen
Markku J. Timonen
SKSirkka Keinänen-Kiukaanniemi
Sirkka Keinänen-Kiukaanniemi

22 October 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAnni Saunajoki
Anni Saunajoki
JAJuha Auvinen
Juha Auvinen
VSVille Saarela
Ville Saarela
JUJanne-Joonas Uusitalo
Janne-Joonas Uusitalo
ILIlmari Leiviskä
Ilmari Leiviskä
MTMarkku Timonen
Markku Timonen
Diabetic retinopathy is a microvascular complication of hyperglycaemia. Little is known about the association of glucose metabolism and retinopathy signs in the non-diabetic middle-aged population. We studied prevalence of retinopathy in a subsample of Northern Finland Birth Cohort study (NFBC1966) of 1809 subjects, at 47 years of age, without previously diagnosed type 2 diabetes and/or blood pressure-lowering medication. All participants underwent clinical evaluations including an oral glucose tolerance test (glucose and insulin values measured at 0, 30, 60 and 120 min) and HbA1c. The retinopathy signs were diagnosed by fundus photographs and classified according to the Eurodiab classification scheme. The overall prevalence of newly diagnosed retinopathy was 1.4%. The retinopathy signs were significantly associated with increased 30 min, 1-h and 2-h glucose levels and 2-h insulin level in an OGTT. After adjustment with systolic blood pressure, only 30 min glucose, 1-h glucose and 2-h insulin levels were associated with retinopathy signs. Our findings show the potential role of 30 min and 1-h post-load glucose and 2-h insulin levels as risk factors for retinopathy lesions among the participants without previously diagnosed diabetes or hypertensive medication.